A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06005974 |
|
Recruitment Status :
Recruiting
First Posted : August 23, 2023
Last Update Posted : February 6, 2024
|
Sponsor:
Recursion Pharmaceuticals Inc.
Information provided by (Responsible Party):
Recursion Pharmaceuticals Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2027 |
| Estimated Study Completion Date : | January 2027 |